The pharmaceutical industry has suffered the biggest impact since the reform and opening up, with unpredictable consequences!
-
Last Update: 2015-04-24
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: sabilan / jiangbianniao in the past half a year, 2015-4-24 is the biggest impact on the pharmaceutical industry since the reform and opening up, and its consequences are unpredictable The characteristics of this price reduction: first, the price reduction is for all drugs For drugs with high prices and a certain profit margin, such as exclusive products and newly launched products without bidding competition, they are not necessarily pressed in place For these products, the mechanism of bidding and price reduction cannot play a role, and administrative coercion is lack of quantifiable pertinence However, for drugs with normal or even low price through bidding for many times, it is unbearable; second, the price reduction covers the whole circulation link Since the drug leaves the factory, the factory price, bidding price, bidding price, medical insurance payment price (payment standard), secondary bargaining, and the price reduction of selected distributors all have different ways of public repression, which does not include the increase of rebate, rebate and other costs, i.e hidden box disguised price reduction However, we just let go of the kickback bribe which should be caught most, and there is no effective measure with pertinence; third, we mainly use administrative means to reduce the price Some government departments use their administrative power to clearly stipulate that the price must be reduced by several percentage points If the price is not reduced, not only the door of this bidding will be closed, but also the bad records will be reported to the provincial and central procurement platforms, and the sales road of enterprises will be sealed forever For this administrative power, there is basically no room for enterprises to circumvent it; fourth, price reduction will be pushed forward in all provinces of the country Since the second half of last year, the crackdown on drug prices has been negligible and has no effect because there are only objections from enterprises and criticisms from the representatives of the NPC and the CPPCC, and there are no stopping measures from the authorities On the contrary, driven by interests, provinces come one after another, and the price reduction among provinces is only the time sequence and the amount of decline, there is no difference between pressure and pressure; fifth, the effect of price reduction affects drug production enterprises and management enterprises Different from the past, which only limited the production enterprises to bid and only pressed the production enterprises' prices, this year also forced the distribution enterprises to press the production enterprises' prices by selecting and pressing the distribution enterprises Regardless of whether the winning enterprises choose the distribution enterprises or the independent distribution enterprises, the hospitals only placed orders and settled accounts with the production enterprises, further excluded the wholesale enterprises, subverted the basic functions of commercial circulation under the market economy; Sixthly, the price reduction will promote the sharp reduction of drug enterprises Nowadays, there are too many pharmaceutical enterprises, and they really need to be greatly reduced But the basic premise of reducing is to survive the fittest and let the enterprises with poor quality and high cost withdraw from the market first At present, such a price reduction can only be achieved by enterprises with many competitors, long sales years and many times of bidding Is this reduction the result that the government hopes to achieve and the society is willing to accept? The result of administrative and comprehensive price reduction can only be the pouring out of bath water and children Now bidding, bid abandonment began to increase, the next step, the cut-off will start to increase, and the next step, the disappearance of low-cost drugs will inevitably increase What kind of enterprise reduction will be driven by such price reduction? At the beginning of this year, the general office of the State Council issued the guiding opinions on improving the centralized purchase of drugs in public hospitals, which made it clear that the centralized purchase of drugs should have four advantages But now such centralized purchase of drugs will only be detrimental to four aspects: first, it is not conducive to breaking the mechanism of supplementing medicine with drugs In the name of arousing the enthusiasm of the hospital, drug price reduction in all links directly and indirectly left the price difference in the hospital, which intensified the supplement of medicine with drugs; second, it was not conducive to reducing the false high price of drugs Regardless of the false high and the false low, the original false low cried to death, the original false high joy, but also easily won the low-cost drug market The price reduction, which violates the laws of science, just promotes the price increase; third, it is not conducive to prevent and curb the corruption in the field of drug purchase and sale As an administrative act, the formulation, implementation, interpretation and amendment of policies are all power intervention, not market mechanism, which will inevitably aggravate commercial bribery; fourthly, they are not conducive to promoting the integration and reorganization of drug production and distribution enterprises, fair competition, and the healthy development of the pharmaceutical industry The competition of drug production and distribution enterprises in such centralized procurement will only be the competition in response to policies, which will inevitably be unfair The development in such centralized procurement will only be the "development" of killing the chicken to get the eggs, drinking poison to quench thirst, which will inevitably be unhealthy The author's unit is Zhejiang Pharmaceutical Industry Association.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.